These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18691726)

  • 1. Cannabis use in Spanish patients with multiple sclerosis: fulfilment of patients' expectations?
    Martínez-Rodríguez JE; Munteis E; Carreño M; Blanco Y; Roquer J; Abanades S; Graus F; Saiz A
    J Neurol Sci; 2008 Oct; 273(1-2):103-7. PubMed ID: 18691726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis and cannabis: a cognitive and psychiatric study.
    Ghaffar O; Feinstein A
    Neurology; 2008 Jul; 71(3):164-9. PubMed ID: 18272863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social capital, political trust and experience of cannabis smoking: a population-based study in southern Sweden.
    Lindström M
    Prev Med; 2008 Jun; 46(6):599-604. PubMed ID: 18329090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Materialist and post-materialist values and cannabis smoking among young adults: a population-based study in southern Sweden.
    Lindström M
    Prev Med; 2007 Apr; 44(4):363-8. PubMed ID: 17289137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis use in the community.
    Robertson JR; Miller P; Anderson R
    Br J Gen Pract; 1996 Nov; 46(412):671-4. PubMed ID: 8978114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Factors associated with the degree of disability among patients of the Spanish Multiple Sclerosis Association of the Community of Madrid].
    Criado-Alvarez JJ; Munugarren R; Romo-Barrientos C
    Rev Neurol; 1997 Oct; 25(146):1539-44. PubMed ID: 9462975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis.
    Banwell E; Pavisian B; Lee L; Feinstein A
    Mult Scler Relat Disord; 2016 Nov; 10():123-126. PubMed ID: 27919478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol misuse and multiple sclerosis.
    Turner AP; Hawkins EJ; Haselkorn JK; Kivlahan DR
    Arch Phys Med Rehabil; 2009 May; 90(5):842-8. PubMed ID: 19406306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlates of driving under the influence of cannabis.
    Jones CG; Swift W; Donnelly NJ; Weatherburn DJ
    Drug Alcohol Depend; 2007 Apr; 88(1):83-6. PubMed ID: 17049755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rural doctors' attitudes to and knowledge of medicinal cannabis.
    Irvine G
    J Law Med; 2006 Aug; 14(1):135-42. PubMed ID: 16937787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illegal cannabis use is common among Danes with multiple sclerosis.
    Gustavsen S; Søndergaard HB; Andresen SR; Magyari M; Sørensen PS; Sellebjerg F; Oturai AB
    Mult Scler Relat Disord; 2019 Aug; 33():5-12. PubMed ID: 31129415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-efficacy, social support and service integration at medical cannabis facilities in the San Francisco Bay area of California.
    Reiman AE
    Health Soc Care Community; 2008 Jan; 16(1):31-41. PubMed ID: 18181813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of adverse health behaviors in multiple sclerosis.
    Marrie R; Horwitz R; Cutter G; Tyry T; Campagnolo D; Vollmer T
    Mult Scler; 2009 Jan; 15(1):105-13. PubMed ID: 18845651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
    Debouverie M
    J Neurol Sci; 2009 Nov; 286(1-2):14-7. PubMed ID: 19691994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential responses to cannabis potency: a typology of users based on self-reported consumption behaviour.
    Korf DJ; Benschop A; Wouters M
    Int J Drug Policy; 2007 May; 18(3):168-76. PubMed ID: 17689363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of drug use and dependence between blunt smokers and other cannabis users.
    Timberlake DS
    Subst Use Misuse; 2009; 44(3):401-15. PubMed ID: 19212929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopathological and cognitive effects of therapeutic cannabinoids in multiple sclerosis: a double-blind, placebo controlled, crossover study.
    Aragona M; Onesti E; Tomassini V; Conte A; Gupta S; Gilio F; Pantano P; Pozzilli C; Inghilleri M
    Clin Neuropharmacol; 2009; 32(1):41-7. PubMed ID: 18978501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased depression in marijuana users.
    Denson TF; Earleywine M
    Addict Behav; 2006 Apr; 31(4):738-42. PubMed ID: 15964704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
    Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
    Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.